Genetic markers associated with complications of hemophilia: A scoping review
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora - Campus Avançado de Governador Valadares
DOI
Abstract
Introduction: Complications of hemophilia, such as hemophilic arthropathies and the
development of inhibitors against coagulation factor, have a great impact on the quality of life
of the patients. The study of factors associated with these complications may contribute to their
prevention.
Objective: This study conducts a scoping review that seeks to identify and discuss genetic
polymorphisms associated with complications of hemophilia A and hemophilia B.
Methods: The methodology was conducted according to PRISMA Extension for Scoping
Reviews (PRISMA-ScR) and PubMed was used as database to identify original articles
published between 2011 and 2021, which associated genetic polymorphisms with
complications of hemophilia.
Results: 23 articles were selected, of which 22 of them identified polymorphisms associated
with higher or lower risk of developing inhibitors in 24 genes and in one article identified
polymorphisms associated with the higher risk of developing hemophilic arthropathy in 18
genes. In both cases, the genes involved were mostly associated with modulation of the immune
and inflammatory response.
Conclusion: Many polymorphisms in genes of coagulation factors and genes related to the
immune and inflammatory response have been associated with the risk of developing inhibitors
and hemophilic arthropathies and are possible molecular markers for treatment-related
complications. However, there are few studies regarding the association of genetic
polymorphisms and musculoskeletal complications.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Embargado

